简体中文 | 繁體中文 | English

Products & Services News

2018-10-24 10:03 Power Integrations Unveils High-Efficiency Flyback Switcher ICs with Integrated 900 V MOSFETs
2018-10-24 09:58 Active-Semi’s New PMICs Reduce Size and Increase Power Density with Leading Field Programable Technology
2018-10-24 09:46 New Nordson EFD Fluid Dispensing Video Gallery is Now Live
2018-10-23 18:21 SmartStream Steps Ahead with New Industry Digital Payments Solution
2018-10-23 18:00 Enevate Secures Funding from LG Chem to Accelerate Fast Charge Li-Ion Battery Technology Development for Electric Vehicles
2018-10-23 15:19 DataCo and SES Networks to Provide Broadband Network for APEC 2018
2018-10-23 15:05 Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
2018-10-23 10:53 Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
2018-10-23 10:13 Sony Corporation Selects ANAQUA for IP Management
2018-10-23 10:11 Smart Link Accelerates Digital Service Expansion with Avaya Cloud Contact Center Solutions
2018-10-22 16:20 Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma
2018-10-22 14:45 Manchester United and True Religion Launch Denim Range
2018-10-22 13:40 Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis
2018-10-22 10:10 Visa Expands Tokenization Partnership With Netflix to Improve Digital Payments Experience Globally
2018-10-22 10:08 RDC Takes Bold Steps in the Fight against Human Trafficking
2018-10-22 09:10 Global Industrial Robot Sales Doubled over the Past Five Years – IFR Reports
2018-10-19 18:31 Alibaba’s Robust Ecosystem Supercharges 2018 11.11 Global Shopping Festival
2018-10-19 18:27 Real-world study shows using Giotrif®/Gilotrif® (afatinib) followed by osimertinib provides a median of 27.6 months of chemotherapy-free time in patients with EGFR mutation-positive NSCLC
2018-10-19 18:18 FLIR Systems Announces Industry-First Deep Learning-Enabled Camera Family
2018-10-19 18:13 EMVCo Publishes Draft EMV® Secure Remote Commerce Specification v0.9 for Public Comment

Business Wire Weibo

Press Releases

Latest Releases